Skip to main content
. 2016 Mar 29;35(6):3227–3235. doi: 10.3892/or.2016.4712

Figure 7.

Figure 7

MRI of BGC-823 tumor-bearing mice. Mice received 1) gadolinium-diethylene triamine pentaacetate (Gd-DTPA), 2) anti-epidermal growth factor receptor (EGFR)-DTPA-Gd, or 3) anti-EGFR-internalizing arginine-glycine-aspartic acid (iRGD)-DTPA-Gd injections via the tail vein at different time points. (A) Precontrast, (B) 15 min, (C) 30 min, (D) 1 h, (E) 2 h, and (F) 3 h.